Guest guest Posted July 19, 2006 Report Share Posted July 19, 2006 " NewsTarget Insider " <insider NTN: FDA caught red handed in scientific fraud Wed, 19 Jul 2006 12:53:41 -0700 NewsTarget Insider Alert (www.NewsTarget.com) HEALTH WARNINGS / CRITICISM ------------------------------ (Please forward to others who may benefit) Yet another drug safety scandal is emerging over the FDA's reliance on fraudulent clinical trial data to approve Ketek, an antibiotic drug. ... From http://www.newstarget.com/019698.html The FDA has once again been caught red-handed ignoring the dangers of a widely-prescribed drug and compromising the health of millions. Internal email messages have now surfaced about how the FDA pushed the antibiotic drug Ketek despite urgent warnings from its senior drug safety scientists. The details of this scandal further highlight the dubious operations of the Food and Drug Administration, which consistently places the profits of drug companies as a higher priority than public health. Ketek was approved under suspicious circumstances in the first place. A key clinical trial for the drug, involving 24,000 patients, was repeatedly found to be fraudulent, according to FDA investigators. One FDA document concluded that Sanofi-Aventis hid safety dangers from the FDA -- dangers the FDA later discovered on its own. One FDA safety scientist, Dr. Cooper, wrote, " I tried to argue that given Aventis's track record in which they have proven themselves to be nontrustworthy that we have to consider the possibility that they are intentionally doing a poor job of collecting the postmarketing data to protect their drug sales. " Dr. David Graham added, " For F.D.A. to refer to its being reassured by postmarketing data from Latin America and Europe as a basis for declaring `Ketek is safe' is in my opinion a great abuse of such surveillance data. " Yet the drug was approved anyway, and the FDA now cites a known fraudulent study to defend the drug and argue against its withdrawal. Four FDA safety officials (Dr. Charles Cooper, Dr. David Ross, Dr. Rosemary Johann-Liang and Dr. David Graham) ultimately sounded the alarm over Ketek's safety in internal emails. As now seems routine at the FDA, they were ignored. (See The Rise and Fall of Rezulin to see another such example.) Story continues at: http://www.newstarget.com/019698.html Also posted today: When fast food restaurants outnumber grocery stores, city residents die earlier from disease http://www.newstarget.com/019697.html Sunscreen offers near-zero protection when rubbed in http://www.newstarget.com/019695.html Migraine with " aura " linked with heart disease risk http://www.newstarget.com/019694.html San Francisco approves universal health care coverage http://www.newstarget.com/019693.html Medics arrested, charged with killing patients during Hurricane Katrina chaos http://www.newstarget.com/019686.html Censorship, intimidation emerges in power struggle over Canadian medical journal and the Canadian Medical Association http://www.newstarget.com/019685.html To your health, - Mike Adams, the Health Ranger =============================================================== Research proves it! Type-2 diabetes can be cured. Now get the book that has taught thousands how. Reverse diabetes in 25 days using safe, natural methods. Results 100% guaranteed or your money back. http://www.truthpublishing.com/HaltDiabetes.html =============================================================== Not yet a r? Sign up at: http://www.NewsTarget.com/ReaderRegistration.html Please DO NOT reply to this email. To contact NewsTarget, email: reply Privacy policy: http://www.newstarget.com/privacypolicy.html ------------------------------ The NewsTarget Insider is published by Truth Publishing, which is solely responsible for all content. Truth Publishing, Inc. 2F, 164 Gong-Yi Rd. Taichung, Taiwan R.O.C. 404 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.